Sfoglia per AUTORE
DA SILVA MG
Collezione AOU Alessandria

  

Items : 7

Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial. in Blood advances / Blood Adv. 2025 Jan 14:bloodadvances.2024014948. doi: 10.1182/bloodadvances.2024014948.
2025
AOU Alessandria
AOU Città della Salute di Torino

da Silva MG; Zilioli VRR; Balzarotti M MD; Boccomini C; Postorino M; Merli M; Careddu MG; Lucchini E; Patti C; Palmas AD; Pascarella A; Michieli M; Vallisa D; Puccini B; Ballerini F; Stefoni V Dr; Cavallo F; Amaducci E; Evangelista A; Civita AM; Alessandria B; Gandossini M; Genuardi E; Ragaini S; Galli A; Bruno B; Rizzo E; Ladetto M; Malcovati L; et alii...

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry. in Haematologica / Haematologica. 2024 Aug 1;109(8):2693-2700. doi: 10.3324/haematol.2023.284678.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Prin R; Wolf D; Arellano E; Ammatuna E; Nordlander A; Cabirta A; Cordoba R; Garcia-Bordallo D; Tragiannidis A; Rodrigues RN; Vehreschild M; Ra?il Z; Hanakova M; Lievin R; Mitrovic M; Garcia-Sanz R; Cvetanoski M; Varricchio G; Bahr NC; Emarah Z; De Ramon C; Meers S; Di Blasi R; Mendez GA; Pantic N; Stojanoski Z; Erben N; Groh A; Cattaneo C; et alii...

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA). in Haematologica / Haematologica. 2023 Jan 1;108(1):22-33. doi: 10.3324/haematol.2022.280847.
2023
AOU Alessandria
AOU Città della Salute di Torino

Hoenigl M; Ammatuna E; Busca A; Corradini P; Rahimli L; Gräfe S; Khostelidi S; Martín-González JA; García-Poutón N; Sacchi MV; Rodrigues RN; Booth S; Sciumè M; Zambrotta G; Hanakova M; El-Ashwah S; Cordoba R; Calbacho M; Bahr NC; Cattaneo C; De Ramón-Sánchez C; Fazzi R; Glenthøj A; Sramek J; Kulasekararaj A; Jindra P; Navrátil M; Piedimonte M; Petzer V; et alii...

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. in American journal of hematology / Am J Hematol. 2023 Dec;98(12):1856-1868. doi: 10.1002/ajh.27093. Epub 2023 Sep 29.
2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

De Paoli L; De Paolis MR; Delgado J; Dimou M; Donaldson D; Catherwood M; Doubek M; Efstathopoulou M; Eichhorst B; Elashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Stamatopoulos K; Ghia P; Stavroyianni N; Trentin L; Cuneo A; Montserrat E; Vitale C; Coscia M; Rambaldi A; Iyengar S; Varettoni M; Yassin M; Pocali B; Vandenberghe E; van Kampen R; et alii...

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. in Journal of hematology & oncology / J Hematol Oncol. 2022 Aug 26;15(1):116. doi: 10.1186/s13045-022-01333-0.
2022
AOU Alessandria

Antic D; Milic N; Chatzikonstantinou T; Scarfò L; Otasevic V; Rajovic N; Allsup D; Alonso Cabrero A; Andres M; Baile Gonzales M; Capasso A; Collado R; Cordoba R; Cuéllar-García C; Correa JG; De Paoli L; De Paolis MR; Del Poeta G; Dimou M; Doubek M; Efstathopoulou M; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Lopez-Garcia A; García-Marco JA; et alii...

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA). in Frontiers in oncology / Front Oncol. 2022 Oct 3;12:992137. doi: 10.3389/fonc.2022.992137. eCollection 2022.
2022
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Busca A; Guidetti A; Glenthøj A; Collins GP; Bonuomo V; Sili U; Seval GC; Hernández-Rivas JÁ; Pagano L; Calbacho M; Giordano A; Cornely OA; Cuccaro A; Marchetti M; Navrátil M; Prezioso L; Nunes-Rodrigues R; Adži?-Vuki?evi? T; De Jonge N; Mladenovi? M; Hanakova M; Zambrotta GPM; Schönlein M; Hoenigl M; Rá?il Z; Nordlander A; Batini? J; Samarkos M; Bilgin YM; et alii...

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. in Haematologica / Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19.
2020
AOU Alessandria
AOU Città della Salute di Torino

Bertoni F; Ladetto M; Cortelazzo S; Piccin A; Grønbæk K; Ferreri A; Santoro A; Molinari A; da Silva MG; Zamò A; Jerkeman M; Paulli M; Novero D; Kolstad A; Barbero D; Schipani M; Mahmoud AM; Ghione P; Favini C; Stefoni V; Diop F; Dahl C; Di Rocco A; Kwee I; Moia R; Evangelista A; Spina V; Eskelund CW; Bruscaggin A; et alii...